Neurocrine Bioscience buy StockNews.com
Start price
18.01.26
/
50%
€114.10
Target price
18.01.27
-
Performance (%)
13.98%
Price
08:06
€130.05
Summary
This prediction is currently active. The prediction currently has a performance of 13.98%. This prediction currently runs until 18.01.27. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -6.615% | -6.615% |
| iShares Core DAX® | 0.437% | 5.897% |
| iShares Nasdaq 100 | 1.057% | 0.920% |
| iShares Nikkei 225® | 1.769% | 1.228% |
| iShares S&P 500 | 0.368% | 1.920% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.75
04.08.24
04.08.24
-
04.08.25
04.08.25
-21.11%
05.08.25
05.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.45
27.07.24
27.07.24
-
27.07.25
27.07.25
-16.98%
28.07.25
28.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.65
20.07.24
20.07.24
-
20.07.25
20.07.25
-16.26%
21.07.25
21.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€125.00
21.06.24
21.06.24
-
21.06.25
21.06.25
-11.16%
22.06.25
22.06.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
-3.38%
24.09.24
24.09.24